Trailing-twelve-month (TTM) revenue is $4.14 Billion with a year-over-year growth of +4.41%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $995,692,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $1,047,560,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $1,040,087,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $1,056,192,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $4,139,531,999 |
Current P/S: $10,715,504,162 market capitalization ÷ $4,139,531,999 TTM revenue = 2.59x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T17:05:11.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.06B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T17:05:11.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Clear Aligner | $2.1B | $3.2B | $3.1B | $3.2B | $3.2B | $3.2B |
| Scanners And Services | $370M | $706M | $662M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $200M | $276M | N/A | N/A | N/A | N/A |
| NETHERLANDS | $0 | N/A | N/A |
$4.14B
$4.14 Billion
+4.41%
vs. $3.96B a year ago (TTM)
+3.57%
5 Year compound annual growth rate
1 Year
+4.41%
3 Year
+3.47%
5 Year
+3.57%
10 Year
+15.91%
15 Year
+16.59%
20 Year
+16.24%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.03B | +$35.95M | +0.90% |
| 2024 | $4.00B | +$136.75M | +3.54% |
| 2023 | $3.86B | +$127.63M | +3.42% |
| 2022 | $3.73B | ($217.95M) | (5.51%) |
| 2021 | $3.95B | +$1.48B | +59.90% |
| 2020 |
TTM Growth
+4.41%
3-Year CAGR
+3.47%
5-Year CAGR
+3.57%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-10T17:05:11.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $769M |
| $790M |
| N/A |
| N/A |
| N/A |
| Other International | $363M | $600M | $858M | $1.0B | $1.3B | $1.5B |
|---|
| SWITZERLAND | $809M | $1.4B | $1.2B | $1.2B | $984M | $921M |
|---|
| UNITED STATES | $1.1B | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B |
|---|
| $2.47B |
| +$65.14M |
| +2.71% |
| 2019 | $2.41B | +$440.30M | +22.39% |
| 2018 | $1.97B | +$493.08M | +33.47% |
| 2017 | $1.47B | +$393.54M | +36.44% |
| 2016 | $1.08B | +$234.39M | +27.72% |
